Gevo, Inc. (GEVO) Stock Rating Lowered by Zacks Investment Research
Gevo, Inc. (NASDAQ:GEVO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.
According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “
Other equities analysts have also recently issued research reports about the company. Rodman & Renshaw reiterated a “buy” rating and issued a $12.00 target price on shares of Gevo in a report on Wednesday, August 9th. HC Wainwright set a $12.00 target price on Gevo and gave the stock a “buy” rating in a report on Friday, August 4th. Finally, ValuEngine upgraded Gevo from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.
Gevo (NASDAQ:GEVO) opened at 0.5634 on Thursday. The company’s market cap is $9.13 million. Gevo has a one year low of $0.53 and a one year high of $10.40. The company’s 50 day moving average price is $0.60 and its 200-day moving average price is $0.80.
Gevo (NASDAQ:GEVO) last announced its earnings results on Thursday, August 3rd. The energy company reported ($0.44) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.54) by $0.10. The firm had revenue of $7.54 million during the quarter, compared to analysts’ expectations of $5.63 million. Gevo had a negative return on equity of 43.79% and a negative net margin of 108.84%. On average, analysts forecast that Gevo will post ($2.00) EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Gevo, Inc. (GEVO) Stock Rating Lowered by Zacks Investment Research” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/16/gevo-inc-gevo-stock-rating-lowered-by-zacks-investment-research.html.
A number of institutional investors and hedge funds have recently bought and sold shares of GEVO. Virtu KCG Holdings LLC boosted its holdings in Gevo by 557.6% during the 2nd quarter. Virtu KCG Holdings LLC now owns 182,390 shares of the energy company’s stock valued at $126,000 after acquiring an additional 154,654 shares during the period. Vanguard Group Inc. boosted its holdings in Gevo by 22.4% during the 2nd quarter. Vanguard Group Inc. now owns 486,959 shares of the energy company’s stock valued at $336,000 after acquiring an additional 89,020 shares during the period. Finally, Sabby Management LLC purchased a new position in Gevo during the 1st quarter valued at $1,274,000. Institutional investors own 13.14% of the company’s stock.
Gevo Company Profile
Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.
Receive News & Stock Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related stocks with our FREE daily email newsletter.